tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Altimmune Sets 2026 Annual Stockholder Meeting Timeline
PremiumCompany AnnouncementsAltimmune Sets 2026 Annual Stockholder Meeting Timeline
29d ago
Altimmune Announces $75 Million Registered Direct Equity Offering
Premium
Company Announcements
Altimmune Announces $75 Million Registered Direct Equity Offering
1M ago
Altimmune (ALT) Raises $75M to Boost Obesity Drug Pipeline
Premium
Market News
Altimmune (ALT) Raises $75M to Boost Obesity Drug Pipeline
1M ago
Unusually active option classes on open January 22nd
PremiumThe FlyUnusually active option classes on open January 22nd
1M ago
Enovix, Serve Robotics, EOG, Altimmune, Globalstar Shake Markets
Premium
Weekend Updates
Enovix, Serve Robotics, EOG, Altimmune, Globalstar Shake Markets
2M ago
Midday Fly By: U.S. oil majors rise on Venezuela news, Versant completes spinoff
Premium
The Fly
Midday Fly By: U.S. oil majors rise on Venezuela news, Versant completes spinoff
2M ago
Altimmune sinks 21% to $3.98 after Phase 2b MASH data
PremiumThe FlyAltimmune sinks 21% to $3.98 after Phase 2b MASH data
3M ago
Pemvidutide’s Strong Phase 2b Data and De-Risked Phase 3 Path in MASH Support Altimmune Buy Rating and $12 Target
Premium
Ratings
Pemvidutide’s Strong Phase 2b Data and De-Risked Phase 3 Path in MASH Support Altimmune Buy Rating and $12 Target
3M ago
Balanced Risk-Reward for Altimmune’s Pemvidutide in a Crowded MASH Landscape Supports Hold Rating
Premium
Ratings
Balanced Risk-Reward for Altimmune’s Pemvidutide in a Crowded MASH Landscape Supports Hold Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100